ADAMTS5 Is a Biomarker for Prediction of Response to Infliximab in Patients with Rheumatoid Arthritis
TSUZAKA, K., ITAMI, Y., TAKEUCHI, T., SHINOZAKI, N., MORISHITA, T.Volume:
37
Language:
english
Journal:
The Journal of Rheumatology
DOI:
10.3899/jrheum.091285
Date:
July, 2010
File:
PDF, 184 KB
english, 2010